Esphera SynBio

BiotechnologySeedOttawa, Canadaespherasynbio.ca

Latest round

Seed

Last raised

Jan 2025

Total raised

$2M

Investors

2

About Esphera SynBio

Established in 2022 and based in Ontario, Canada, Esphera SynBio Inc. operates as a biopharmaceutical company that develops vaccines for cancer and infectious diseases. Esphera SynBio's core product offerings involve the engineering of cells to produce exosomes that are tailored with specific targeting moieties and loaded with various therapeutic agents, including proteins and RNA species. This approach allows for the delivery of immunostimulatory payloads that can transform typically protumourigenic and immunosuppressive tumour-exosomes into agents that modify the tumor microenvironment (TME) and serve as personalized cancer vaccines. Target markets for these products include oncology and immunotherapy sectors, with applications extending to research institutions and healthcare facilities in North America and Europe.

Who invested in Esphera SynBio

2 investors across 1 round

See all investors in Esphera SynBio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jan 7, 2025

    Amount

    $2M

    Investors

    Locked

Questions about Esphera SynBio

Who invested in Esphera SynBio?

Esphera SynBio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Esphera SynBio raised?

Esphera SynBio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Esphera SynBio last raise money?

Esphera SynBio's most recent round on record is a Seed, in Jan 2025.

What does Esphera SynBio do?

Established in 2022 and based in Ontario, Canada, Esphera SynBio Inc.

Where is Esphera SynBio headquartered?

Esphera SynBio is headquartered in Ottawa, Canada.

Which VCs invest in companies like Esphera SynBio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Esphera SynBio's stage. Their profiles are linked below.

Raising like Esphera SynBio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.